您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8473 处方药 8099 非处方药 268 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 意大利药房
产地国家: 意大利
所属类别: 作用于呼吸系统药物->平喘药物
处方药:处方药
包装规格: 100毫克/10毫升 3支
计价单位:
   
生产厂家中文参考译名:
ABC Farmaceutici
生产厂家英文名:
ABC Farmaceutici
该药品相关信息网址1:
http://trialx.com/treatment/doxofylline-ansimar-indications-side-effects-dosage-interactions-information/
原产地英文商品名:
ANSIMAR 100mg/10ml 3vials (minimum order quantity:10)
原产地英文药品名:
DOXOFYLLINE
中文参考商品译名:
安赛玛注射液 100毫克/10毫升 3支 (最少订购Qty: 10 )
中文参考药品译名:
多索茶碱
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
Bronchial asthma
英文适应病症2:
Lung disease
临床试验期:
完成
中文适应病症参考翻译1:
支气管哮喘
中文适应病症参考翻译2:
肺部疾病
药品信息:

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201142523414613.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------
部分中文多索茶碱处方资料(仅供参考)

药品名称:多索茶碱 

英文药名:Doxofylline 

其他名称:Ansimar、Maxivent、安赛玛、安泰玛、多索菲林、枢维新。 

药理作用:本品抑制磷酸二酯酶,松弛支气管平滑肌作用较氨茶碱强,另外对组胺诱发的豚鼠咳嗽具有镇咳作用。 

临床应用:支气管哮喘及伴支气管痉挛的肺部疾病。

禁忌症:凡对多索茶碱或黄嘌呤的衍生物类药物过敏、急性心肌梗死患者及哺乳期妇女禁用。 

不良反应:少数患者服药后有心悸、窦性心动过速、上腹不适、纳差、恶心、呕吐、兴奋、失眠等症状。 

制剂规格:
(1)片剂0.2g;
(2)胶囊剂0.2g;
(3)注射剂:100mg/ml。 

注意事项:
(1)患有甲亢、窦性心动过速、心律失常者,请遵医嘱用药。
(2)茶碱类药物个体差异较大,多索茶碱剂量亦要视个体病情变化选择最佳剂量和用药方法。与氟喹诺酮类药物联用时,剂量酌减。
(3)妊娠期妇女慎用。
(4)严重心、肺、肝、肾功能异常者以及活动性胃、十二指肠溃疡者慎用。 

Doxofylline (Ansimar) Side Effects, Dosage, Interaction Information
What is Doxofylline (Ansimar)?
Doxofylline is a type of enzyme inhibitor drugs that is used to treat Asthma. In animal and human studies, it has shown similar efficacy to theophylline but with significantly less side effects. Doxofylline belongs to category of enzyme inhibitor activity drugs. Specifically, Doxofylline is a new generation long acting oral methylxanthine derivative. Methylxanthines are phosphodiesterase inhibitors. Doxofylline is available as the Brand Name, Ansimar. Doxofylline also has antitussive and bronchodilator affects, and acts as a phosphodiesterase inhibitor.

Indication for use of Doxofylline (Anismar)
For maintenance therapy in patients suffering with Asthma and Chronic Obstructive Pulmonary Disease (COPD).

Side Effects of Doxofylline (Anismar)
No CNS and CVS side effects.
Doxofylline has a prolonged bronchodilator effect and unlike theophylline it has least adenosine interactions.
It is highly safe in smokers.
There is no sleep disturbances and no effects on gastric secretions with doxofylline.

Dosages of Doxofylline (Anismar)
Adult:400mg once a day. Single dose, administration in the evening reduces nocturnal, symptoms and helps to keep the patients complaint free during the day.

However, in certain cases, 400mg twice daily is recommended on the basis of the clinical response. Doses as high as 1200mg/day (400mg 3 times  day) may also be prescribed .

Precautions while using Doxofylline (Anismar)
Initial treatment of acute episodes of bronchospasm.

---------------------------------------------------------------
 详细处方信息以本药内容附件PDF文件(201142523414613.pdf)的“原文Priscribing Information”为准
---------------------------------------------------------------

更新日期: 2014-06-05
附件:




201142523414613.pdf    

 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com